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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: The genomes of different Aggregatibacter actinomycetemcomitans
(A actinomycetemcomitans) strains contain many strain-specific genes and genomic islands
(defined as DNA found in some but not all strains) of unknown functions. Genetic analysis
for the functions of these islands will be constrained by the limited availability of genetic
markers and vectors for A actinomycetemcomitans. In this study, we tested a novel genetic
approach of gene deletion and restoration in a naturally competent A actinomycetemcomitans
strain D7S-1.
Methods: Specific genes’ deletion mutants and mutants restored with the deleted genes were
constructed by a markerless loxP/Cre system. In mutants with sequential deletion of multiple
genes loxP with different spacer regions were used to avoid unwanted recombinations
between loxP sites.
Results: Eight single-gene deletion mutants, four multiple-gene deletion mutants, and two
mutants with restored genes were constructed. No unintended non-specific deletion mutants
were generated by this protocol. The protocol did not negatively affect the growth and biofilm
formation of A actinomycetemcomitans.
Conclusion: The protocol described in this study is efficient and specific for genetic manipula-
tion of A actinomycetemcomitans, and will be amenable for functional analysis of multiple
genes in A actinomycetemcomitans.
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Gram-negative facultative Aggregatibacter actino-
mycetemcomitans (A actinomycetemcomitans) is recog-
nized as an etiology of periodontitis.1 There are six
serotypes of A actinomycetemcomitans based on the
structural distinction of O-antigen of lipopolysaccharide.2,3
Each serotype represents a distinct clonal lineage that
shows little recombination with strains of other serotypes.
Moreover, different serotypes or genotypes of A actino-
mycetemcomitans may display distinct disease-association
patterns.4e6 However, little detailed information has been
known of the underlying genomic variation among strains.
Recent studies from our laboratory have revealed
remarkable genomic differences among A actino-
mycetemcomitans strains.7,8 For example, 0.4e19.5% of
the total protein-coding genes in each genome could differ
between strains. Cumulatively, among the 14 A actino-
mycetemcomitans, there are >1200 accessory genes (i.e.,
genes that are not shared by all strains), many of which
reside in genomic islands and have no known functions.
Approaches to assess the functions of these accessory genes
need to be efficient, able to monitor multiple genes if
necessary, and easily adaptable to assays in a variety of
experimental conditions.
The genetic tools for A actinomycetemcomitans are
limited. The most common genetic markers used for A acti-
nomycetemcomitans are the resistance gene for spectino-
mycin, tetracycline, kanamycin or chloramphenicol.9e14 In
order to study the functions ofmultiple genes,more than one
marker is required for deletion or complementation. This
may pose some technical difficulties. This studywas initiated
to test a genetic protocol, which is amenable for complex
genetic analysis, which involved multiple genes. Our future
goal is to examine the functions of accessory genes (such as
those carried on genomic islands) of A actino-
mycetemcomitans. A markerless gene deletion protocol
using loxP with different spacer regions was developed for
single or sequential deletions of multiple DNA in A actino-
mycetemcomitans. Both the accessory genes and core genes
(i.e., genes shared by all A actinomycetemcomitans strains)
were tested in deletion experiments. The results demon-
strated that the protocol is highly efficient and specific in
gene deletion and restoration. The protocol for genetic
manipulation has not led to unintended deleterious
effects to the growth and biofilm formation of A
actinomycetemcomitans.
Materials and methods
Bacterial strains, plasmids and growth conditions
The bacteria strains and plasmids used in this study are
listed in Tables 1 and 2. Bacteria were grown either in
a solid Trypticase Soy Broth agar (sTSB agar) containing 3%
trypticase soy broth, 0.3% yeast extract, 5% horse serum
and 1.5% agar, or Modified Trypticase Soy Broth (mTSB)
composed of 3% trypticase soy broth and 0.6% yeast extract
at 37C in air supplemented with 5% CO2. The pBluescript II
KS plasmids (Stratagene, La Jolla, CA, USA) were replicated
in Escherichia coli host strain DH5a by standard methods.15For selection of transformants or mutants, spectinomycin
(Spe, 50 mg/mL), tetracycline (Tc, 4 mg/mL) or ampicillin
(Amp, 100 mg/mL) were added to the media.
DNA manipulations
A actinomycetemcomitans genomic DNA was prepared by
the phenol-chloroform method or GenElute Bacterial
genomic Kit (Sigma, Saint Louis, MO, USA). Plasmid DNA was
isolated by QIAprep Spin Miniprep kit (Qiagen, Valencia, CA,
USA). Transformation of E coli was carried out by electro-
poration using a MicroPulser (BioRad, Hercules, CA, USA).
Restriction enzymes, T4 DNA ligase and Taq DNA poly-
merase were purchased from New England BioLabs (New
England BioLabs Inc., Ipswich, MA, USA), and used as sug-
gested by the manufacturer. The polymerase chain reac-
tions (PCR) were performed as described previously15 and
the PCR products were purified with a QIAquick PCR puri-
fication kit and a QIAquick gel extraction kit (Qiagen,
Valencia, CA, USA). Table 3 lists the sequences of primers
used for cloning, deletion, and mutation.
Construction of vectors containing the wildtype
loxP-Sper-loxP cassette and its variants
Vectors cloned with a spectinomycin-resistance marker
(Spe) flanked by two loxP sites or two of its variants were
generated. As an example, for the construction of the
Sper cassette with the wildtype loxP (loxPW ) sites, two
partially complementary oligonucleotides were synthesized
by Integrated DNA Technologies (Coralville, IA, USA):
50-TCGACACCACGTGGATCCATAACTTCGTATAATGTATGCTA
TACGAAGTTATCTGCAGATAACTTCGTATAATGTATGCTATACG
AAGTTATGTCGACACGTGGTG-30, and 30-GATCCACCACGTG
TCGACATAACTTCGTATAATGTATGCTATACGAAGTTATCTGCA
GATAACTTCGTATAATGTATGCTATACGAAGTTATGGATCCACG
TGGTG-30 (loxP sites are underlined, and bold letters indi-
cate the spacer sequence of loxP. Sal I, Dra III, Bam HI, and
Pst I were engineered in these two oligonucleotides). These
two DNA fragments were annealed, and cloned into
pBluescript II KS at the Bam HI and Sal I sites. A 1.1 kb Sper
cassette released from Pst I-digested plox2-Spe plasmid12
was inserted in the Pst I site between two loxPW sites to
generate a plasmid bearing a loxPW-Sper-loxPW gene
cassette. All recombinant plasmids were confirmed by
sequencing the PCR products with T3 and T7 primers. With
the same strategy, plasmids with variants of the loxP-Sper-
loxP cassette were generated (see Table 2 for variant loxP
spacer sequences). The variant cassettes contained a pair
of mutant loxP with one or two bases altered in the loxP
spacer region based on their specificity in recombination.16
This will allow successive deletions with the loxP/Cre
system without interference from existing loxP sites of the
genome.
Site-specific gene deletion with the loxP /Cre
system
The strategy for gene deletion with the loxP/Cre system
has been described previously17. Briefly, three steps
were involved: (1) construction of the donor DNA with the
Table 1 Bacterial strains.
Strains Feature descriptions Annotation of affected gene(s); deletion size in bp
D7S-1 Wildtype, fimbriated N/A
D7SDltxA::Sper Deletion of ltxA replaced with a loxPW-Sper-loxPW LtxA; 934
D7SDltxA Derivative of D7SDltxA::Sper; Sper removed leaving a loxPW
D7SDcdtB::Sper Deletion of cdtB replaced with a loxP6-Sper-loxP6 CdtB; 289
D7SDcdtB Derivative of D7SDcdtB::Sper; Sper removed leaving a loxP6
D7SDacrB::Sper Deletion of acrB replaced with a loxP1-Sper-loxP1 acriflavine resistance protein; 566
D7SDacrB Derivative of D7SDAcrB::Sper; Sper removed leaving a loxP1
D7SDpulG::Sper Deletion of pulG replaced with a loxP1-Sper-loxP1 pseudopilin; 617
D7SDpulG Derivative of D7SDpulG::Sper; Sper removed leaving a loxP1
D7SDp2579::Sper Deletion of gene “p2579” replaced with a loxP3-Sper-loxP3 PTS system; 989
D7SDp2579 Derivative of D7SDp2579::Sper; Sper removed leaving a loxP3
D7SDp2639::Sper Deletion of gene “p2639” replaced with a loxP1-Sper-loxP1 oligopeptide transport system permease protein (p2639); 662
D7SDp2639 Derivative of D7SDp2639::Sper; Sper removed leaving a loxP1
D7SD16::Sper Deletion of the 16-island replaced with a loxP5-Sper-loxP5 helicase, hypothetical protein, type III DNA modification
methylase, protein of unknown function and hypothetical protein;
7845
D7SD16 Derivative of D7SD16::Sper; Sper cassette removed leaving a loxP5
D7SD285::Sper(R) Deletion of the 285-island replaced with a loxP1-Sper-loxP1 integral membrane protein, MarR-family transcriptional regulator,
AcrA protein, hypothetical protein, SecA-related protein and
acriflavine resistance protein; 5087
D7SD285(R) Derivative of D7SD285::Sper(R); Sper cassette removed leaving
a loxP1
D7SDltxADcdtB::Sper Derivative of D7SDltxA with a deletion in cdtB replaced with
a loxP6-Sper-loxP6
See above; 1223
D7SDltxADcdtB Derivative of D7SDltxADcdtB::Sper; Sper removed leaving a loxP6
at cdtB and a prior loxPW at ltxA
D7SDltxADcdtBD16::Sper Derivative of D7SDltxADcdtB with a deletion in the 16-island
replaced with a loxP5-Sper-loxP5
See above; 9068
D7SDltxADcdtBD16 Derivative of D7SDltxADcdtBD16::Sper; Sper removed leaving
a loxP5
D7SDltxADcdtBD285::Sper Derivative of D7SDltxADcdtB with a deletion in the 285-island
replaced with loxP1-Sper-loxP1
See above; 6310
D7SDltxADcdtBD285 Derivative of D7SDltxADcdtBD285::Sper; Sper removed leaving
a loxP1
D7SDltxADcdtBD16D285::Sper Derivative of D7SDltxADcdtBD16 with a deletion within the 285-
island replaced with loxP1-Sper-loxP1
See above; 14155
D7SDltxADcdtBD16D285 Derivative of D7SDltxADcdtBD16D285::Sper; Sper cassette
removed leaving a loxP1
D7SD285C::Sper(R) Derivative of D7SD285(R) restored with a loxP4 -Sper-loxP4 and
the 285-island
N/A
D7SD285C(R) Derivative of D7SD285C::Sper(R); Sper removed leaving a loxP4
D7SDltxADcdtBD285C::Sper Derivative of D7SDltxADcdtBD285 restored with a loxP4-Sper-
loxP4 and the 285-island
See above; 1223
D7SDltxADcdtBD285C Derivative of D7SDltxADcdtBD285C::Sper; Sper removed leaving
a loxP4
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Table 2 Plasmids used in this work.
Plasmid Feature descriptions Reference
pBluescript II KS Ampr; Cloning vector Stratagene
pAT/Cre Tcr; shuttle plasmid of E coli and A actinomycetemcomitans; pPK1 derivative
containing the cre gene
17
ploxw-Sper Ampr,Sper; pBluescript II KS derivative containing two wildtype loxP sites (the
loxPW spacer sequence: ATGTATGC) flanking a Sper gene
This work
plox1-Sper Ampr,Sper; pBluescript II KS derivative containing two mutant loxP1 sites (the
loxP1 spacer sequence: ATGcATGCa) flanking a Sper gene
This work
plox2-Sper Ampr,Sper; pBluescript II KS derivative containing two mutant loxP2 sites (the
loxP2 spacer sequence: ATGgATGCa) flanking a Sper gene
This work
plox3-Sper Ampr,Sper; pBluescript II KS derivative containing two mutant loxP3 sites (the
loxP3 spacer sequence: ATGTATaCa) flanking a Sper gene
This work
plox4-Sper Ampr,Sper; pBluescript II KS derivative containing two mutant loxP4 sites (the
loxP4 spacer sequence: AaGTATcCa) flanking a Sper gene
This work
plox5-Sper Ampr,Sper; pBluescript II KS derivative containing two mutant loxP5 sites (the
loxP5 spacer sequence: ATGTgTaCa) flanking a Sper gene
This work
plox6-Sper Ampr,Sper; pBluescript II KS derivative containing two mutant loxP6 sites (the
loxP6 spacer sequence: AgaTcTGCa) flanking a Sper gene
17
a The lower case letter(s) indicate the altered base(s) located in the variant loxP spacer sequences.
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upstream and downstream of the gene to be deleted; (2)
allelic replacement of the target gene in A actino-
mycetemcomitans by natural transformation; and (3)
removal of the loxP -Sper-loxP leaving a loxP scar at the
deletion site (see Fig. 1A for an example).
In this study, two approaches were used to construct the
donor DNA. The first approach was by the in vitro ligation.
Two pairs of primers were designed to amplify the upstream
and downstream homologous DNA fragments flanking the
deletion target. A Dra III site was engineered in the prox-
imal end of the two homologous DNA fragments (Table 3).
Approximately 1600 ng of PCR amplicons of the upstream
and downstream homologous DNA fragments isolated by
QIAquick PCR purification kit (Qiagen, Valencia, CA, USA),
were mixed with approximately 800 ng of recombinant
plasmid with a loxP-Sper-loxP cassette, which had Dra III
sites in each end. The mixture was digested with Dra III at
37C for 1 hour, then purified by the QIAquick PCR purifi-
cation kit, and ligated at 16C overnight. After heat inac-
tivation of the ligation reaction, the ligation mixture was
used directly for transformation. The alternative method
for donor DNA preparation involved cloning. Two pairs of
primers were designed to generate the upstream and
downstream homologous regions (>500 bp) flanking the
deletion target by PCR, and the DNA fragments were cloned
sequentially into the upstream and downstream of the loxP-
Sper-loxP cassette in a recombinant plasmid constructed
above. The DNA fragment containing the homologous
regions and the loxP-Sper-loxP cassette was then released
from the vector by restriction enzyme digestion, purified
and served as donor DNA. Gene transfer by natural trans-
formation was performed as described previously.18 The
transformants (with the target gene replaced by the loxP-
Sper-loxP cassette) were verified by PCR and designated as
“intermediate” gene deletion mutants. In the final step,
the Spe-resistance marker was removed by introducinga vector containing Cre as described previously.17 Mutants
of A actinomycetemcomitans strain D7S-1 with deletions of
multiple genes were constructed step-wise with the loxP/
Cre system as described above.
Restoration of the deleted genes
Essentially the reversal of the process of the deletion is
applied for gene restoration (see Fig. 1B for an example).
Two fragments (one of which includes the deleted region)
were constructed by PCR amplification. The two fragments
were ligated to a loxP-Sper-loxP cassette in vitro and the
DNA mixture was used directly for transformation. The
transformants were identified from selective media and the
resistance marker spliced out leaving a loxP scar in the
genome. The gene-restored mutants were then confirmed
by PCR analysis and sequencing as before.
Bacterial growth assays in broth
Bacterial suspensions were prepared by the indirect
suspension method.19 Briefly, bacteria were collected from
agar plates with a sterilized plastic loop and spread as
a thin layer slightly above the solution face on the test tube
wall. The bacteria were dispersed into the mTSB broth by
mixing with a vortex, and the above steps were repeated
several times. The optical density (OD) of each starter
bacterial suspension was determined (OD w 0.25e0.3) and
then diluted 1:5 with fresh broth. Aliquots of 20 mL of the
bacterial suspension were transferred to each well of a 100-
well Bioscreen C plate preloaded with 180 mL of prewarmed
fresh media. To prevent evaporation of the liquid culture,
15 mL of mineral oils were added in each well. The plate
was incubated at 37C for 40 hours with continuous shaking,
and the absorbance at 420e580 nm visible light was
recorded every 30 minutes. Wells containing media served
118 Y.-A. Cheng et al.as background controls. The data from duplicate wells for
each strain were averaged to represent one data point. The
growth of each strain was independently tested at least
three times on different dates.
To calculate the doubling time, the exponential phase of
the growth was first defined as the time period between
two measurements of the OD: the minimum OD þ 0.1 and
the maximum OD e 0.1. After subtraction of the back-
ground OD (OD of the media only; without bacteria), the OD
was transformed into log2 (OD). A linear regression of the
data points was performed and accepted if the R2 was
>0.95, otherwise the experiments were repeated. The
reciprocal of the slope gives the doubling time directly. The
comparison of doubling time and maximum OD among
strains was performed with SPSS 15.0 by using the Student
t test or the analysis of variance (ANOVA).
Biofilm formation assay
Aliquots of 20 mL of bacterial suspension of A actino-
mycetemcomitans were prepared as described above and
transferred into wells preloaded with 180 mL of prewarmed
media. The plate was incubated at 37C for 48 hours in air
supplemented with 5% CO2. After incubation, the media was
gently removed and the wells were washed twice with
200 mL PBS, then air dried. A solution of 0.1% crystal violet
was used to stain the dried wells for 10 minutes. Subse-
quently, the staining solution was removed, and the wells
were washed twice with 200 mL PBS, then air-dried again.
The stained biofilms were destained with 100% (v/v)
ethanol for 5 minutes. The absorbance of the dye was
quantified at 540 nm visible light using a microplate reader.
Strains were tested in triplicate for each condition tested.
Results
Construction of mutants
Eight single-deletion mutants were constructed (Table 1).
Each set included an “intermediate” mutant with Spe resis-
tance marker and a final markerless mutant. The deletion
targets were selected to include well-studied core genes
which were unlikely to affect growth and biofilm formation
(ltxA and cdtB), four small accessory genes of unknown
functions and two genomic islands of unknown functions.
Four sets of mutants with deletion of multiple genes
were constructed (Table 1). They were made to test the
protocol for sequential deletions by the Cre/loxP system.
The step-wise process of a quadruple gene-deletion mutant
strain D7SDltxADcdtBD16D285 is given here as an example.
The construction began from the single gene deletion
mutant D7SDltxA with a loxPW scar. This mutant was
transformed with the genomic DNA from the
D7SDcdtB::Sper (with loxP6 sites flanking the Sper marker)
mutant. The transformants were identified and the resis-
tance marker subsequently removed, leaving a loxP6 scar in
the genome. The same steps were repeated to generate
a triple knockout mutant D7SDltxADcdtBD16 and the
quadruple knockout mutant D7SDltxADcdtBD16D285
(leaving a loxPW, a loxP6, a loxP5 and a loxP1scars in the
genome).Growth and biofilm formation
Table 4 provides a summary of the results of the growth
assays. Most of the mutants did not show altered growth.
However, it was noted that a mutant with a deletion of the
285-island appeared to grow faster than the wildtype. The
restoration of the island in the deletion mutant reduced the
growth rate to the level of the wildtype D7S-1. The genetic
map of the 285-island and its deletion and restoration are
illustrated in Figs. 1A and 1B. The island is 6660 bp, and has
6 predicted ORFs. The deleted region and the restored
region are also marked. The difference in the wildtype and
the mutant restored of the 285-island was the loxP4 scar
within the downstream hypothetical protein HP2. The
insertion of a loxP within HP2 is not expected to change the
phenotype.
Biofilm formation was evaluated for the wildtype D7S-1
and mutants. There were no significant differences in the
biofilm formation among strains. Instead, the primary
determinant for biofilm formation was the fimbriation
status of the test strains (data not shown).Discussion
The long-term goal of this study was to identify a suitable
genetic approach to examine the functions of strain-
specific genes of A actinomycetemcomitans. Several
genetic protocols have been developed for mutagenesis and
gene complementation of A actinomycetemcomitans,
including allelic exchange and homologous integration,20e22
insertional mutagenesis23,24 and transposon-mediated
mutagenesis.14,25,26 These methods involve a cloning step,
which could prolong the experiments or present an obstacle
if the cloned products are toxic to the E coli host. Our
approach for genetic manipulation could prepare the
recombinant DNA by PCR amplification and in vitro ligation,
and use it directly as donor DNA for competence-mediated
gene transfer. The transformation frequencies were
approximately 104 to 105 for naturally competent
A actinomycetemcomitans.12 A typical experiment gener-
ated approximately 100 to 1000 transformants with 2  107
competent bacteria. A gene deletion mutant could be
generated in <1 week with minimal work.
In this study, the Cre/loxP recombination system was
employed to delete the antibiotic resistance marker. This
approach was taken primarily for the ease of construction
of mutants with deletion of multiple genes, and to avoid
the possible effects of antibiotic resistance markers to the
phenotypes of the bacteria. The Cre recombinase catalyzes
co-factor independent recombination between two loxP
sites, which consist of two 13 bp inverted repeats separated
by an asymmetric 8 bp spacer region.27 The Cre/loxP
recombination system shows high recombination efficiency
and has been widely used in eukaryotes. For prokaryotic
organisms, Cre/loxP has been involved in genetic works for
E coli28,29, Lactobacillus plantarum, 30 and other species
of Gram-negative bacteria,31e33 but limited in use for
A actinomycetemcomitans.17,34
A novel feature of our approach is the use of different
loxP for construction of mutants with deletion of multiple
genes. Consecutive deletion of genes using the same
Table 3 List of primers.
Primers Sequences(5’/3’)a Location and usageb
ltxA-UpF-Apa ATAGGGCCCGGCATTAACTAATG Upstream of ltxA (600424-600411); for deletion of ltxA
ltxA-UpR-Xho TATCTCGAGTATTCCTCAAGCATTC Upstream of ltxA (599669-599684); for deletion of ltxA
ltxA-DwF-Spe TATACTAGTAAAGGTCGCACCGGT Downstream of ltxA (598753-598738); for deletion of ltxA
ltxA-DwR-Sac TACGAGCTCTTGAGGTGAAATTGT Downstream of ltxA (597736-597750); for deletion of ltxA
ltxA-IntF TGAACATATCGCGAATCAGC Inside of ltxA (599431-599412); for confirmation of ltxA deletion
ltxA-IntR ACGTGTAACGGCATGTTGAA Inside of ltxA (598876-598895); for confirmation of ltxA deletion
cdtB-UpF-Apa ATAGGGCCCATTGATACGCCAACGAA Upstream of cdtB (2171088-2171072); for deletion of cdtB
cdtB-UpR-Xho CACCTCGAGAGCAAGCACGTGAA Upstream of cdtB (2170488-2170501); for deletion of cdtB
cdtB-DwF-Spe TACACTAGTACCAATGCGGATACCTA Downstream of cdtB (2170192-2170176); for deletion of cdtB
cdtB-DwR-Sac AATGAGCTCTCTTCATCCAAGAATGG Downstream of cdtB (2169234-2169250); for deletion of cdtB
cdtB-IntF CGTGGTAAATGTGCGTCATG Inside of cdtB (2170482-2170463); for confirmation of cdtB deletion
cdtB-IntR TTACAGTGCATGCTTTGGCC Inside of cdtB (2170206-2170225); for confirmation of cdtB deletion
16-UpF GGCGTCTGCTCGGTGATAA Upstream of the 16-island (1997280-1997262); for deletion of the 16-island
16-UpR-Dra TGCACGTGGTGTTGTATGACGTAGA Upstream of the 16-island (1996774-1996787); for deletion of the 16-island
16-DwF-Dra ATCACGTGGTGTTCCAACACGGC Downstream of the 16-island (1988918-1988907); for deletion of the 16-island
16-DwR CCAATTCGGTGCGGACATTCC Downstream of the 16-island (1988335-1988355); for deletion of the 16-island
16-IntF CGGCGGTCAGAAGATTGGG Inside of the 16-island (1991452-1991434); for confirmation of the 16-island
deletion
16-IntR AGTCCTGCTCACCGCCACG Inside of the 16-island (1990908-1990926); for confirmation of the 16-island
deletion
285-UpF TAAACCTACCGCCGAAGCG Upstream of the 285-island (1056124-1056106); for deletion of the 285-island;
285-UpR-Dra CTCACGTGGTGATGGTGTTGTTA Upstream of the 285-island (1055356-1055367); for deletion of the 285-island
285-DwF-Dra TACACGTGGTGCTGATTATTTGGGT Downstream of the 285-island (1050256-1050243); for deletion of the 285-
island
285-DwR CTGCCTTATTCCACTTCCACCC Downstream of the 285-island (1049587-1049608); for deletion of the 285-
island
285-IntF GCGCTGCAACATCATAAAGC Inside of the 285-island (1052447-1052428); for confirmation of the 285-island
deletion
285-IntR CCAGCCACAGCCATAATCAA Inside of the 285-island (1051915-1051934); for confirmation of the 285-island
deletion
285s-UpF TGGAATTCTATCCTCCGGTGTTACTGA Upstream of the 285-island (1055865-1055839); for complementation of the
285-island
285s-UpR II TTCACGTGGTGTCAGCACCATTAAGACG Upstream of the 285-island (1050253-1050269); for complementation of the
285-island
285s-DwF II TACACGTGGTGTTATTTGGGTGTGGGGT Downstream of the 285-island (1050252-1050236); for complementation of the
285-island
285s-DwR II CCAATCTTGGTGCGTCATCAAGGCTAAT Downstream of the 285-island (1049645-1049672); for complementation of the
285-island
acrB-UpF TCTCGCAGAACGGGTTTATCAAACAGTAT Upstream of acrB (1054510-1054538); for deletion of acrB
acrB-UpR ATCACGTGGTGTTCGCCTAAGGATATTCA Upstream of acrB (1055313 -1055296); for deletion of acrB
acrB-DwF CGCACGTGGTGTAATCTTTTTGAAAAAATACC Downstream of acrB (1055878-1055898); for deletion of acrB
(continued on next page)
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Table 3 (continued )
Primers Sequences(5’/3’)a Location and usageb
acrB-DwR GATAAGTTTGTCGCGTGGAATGGTTAAGT Downstream of acrB (1056805-1056777); for deletion of acrB
acrB-IntF GCGTGGTGATGGTGTTGTTA Inside of acrB (1055348-1055367); for confirmation of acrB deletion
acrB-IntR ATCCTCCGGTGTTACTGACG Inside of acrB (1055856-1055837); for confirmation of acrB deletion
p2579-UpF GGCGTTTTTACAACCTGCAGAAGCCTTGAAA Upstream of gene encoding protein with p-02579 (429323-429353) ; for deletion
of p-cluster 02579
p2579-UpR TTCACGTGGTGTAGACGGCGTTTCTTTCTAC Upstream of gene encoding protein with p-02579 (429918-429937); for deletion
of p-cluster 02579
p2579-DwF ATCACGTGGTGAAATTCTCTCCTCTTCACGA Downstream of gene encoding protein with p-02579 (430925-430944); for
deletion of p-cluster 02579
p2579-DwR CGTTAAGCGGATAAATTCCGGCCATGATGTT Downstream of gene encoding protein with p-02579 (431650-431620); for
deletion of p-cluster 02579
p2579-IntF GGCAATTTGGCACTTTTGTT Inside of gene encoding protein with p-02579 (430732-430713); for
confirmation of p-cluster 02579 deletion
p2579-IntR GAAACGCGTACCTTCGGTAA Inside of gene encoding protein with p-02579 (430142-430161); for
confirmation of p-cluster 02579 deletion
p2639-UpF ATCGTGCAGGAGATTTGGACATCACCAG Upstream of gene encoding protein with p-02639 (651694-651721); for deletion
of p-cluster 02639
p2639-UpR ATCACGTGGTGGAAATTGTCCCCAACGTA Upstream of gene encoding protein with p-02639 (652650-652633); for deletion
of p-cluster 02639
p2639-DwF AACACGTGGTGTAAAGCACGCGCTGCGTC Downstream of gene encoding protein with p-02639 (653311-653328); for
deletion of p-cluster 02639
p2639-DwR CATCACCATGTCGATTTTGCCGCCGAAAT Downstream of gene encoding protein with p-02639 (654021-653993); for
deletion of p-cluster 02639
p2639-IntF GAAGTGATGGCGAACATTGA Inside of gene encoding protein with p-02639 (652780-652799); for
confirmation of p-cluster 02639 deletion
P2639-IntR CCTTGGCGGTACGAATAAAA Inside of gene encoding protein with p-02639 (653280-653261); for
confirmation of p-cluster 02639 deletion
pulG-UpF GCGCTGAGCAACAATAACAAACTCATCGT Upstream of pulG (611176-611204); for deletion of pulG
pulG-UpR ATCACGTGGTGTAGAGCGTTTTTCCACGT Upstream of pulG (611960-611943); for deletion of pulG
pulG-DwF ATCACGTGGTGTTGATGGGTATTTTTGGG Downstream of pulG (612576-612593); for deletion of pulG
pulG-DwR GGTGGCTATTCCGTTCAAGATTTACAACA Downstream of pulG (613537-613509); for deletion of pulG
pulG-IntF TGCCGTTCGTTTATTTTTCC Inside of pulG (612543-612524); for confirmation of pulG deletion
pulG-IntR TGACGCAAGCACTCAAAGAT Inside of pulG (611972-611991); for confirmation of pulG deletion
Spe-UpF GCAGGTCGATTTTCGTTC Inside of Sper gene; for identification of Sper intermediate deletion mutants
Spe-DwR GCCACTGCATTTCCCGCATA Inside of Sper gene; for identification of Sper intermediate deletion mutants
a Underlined sequences are the restriction sites
b The nucleotide coordinates of the primers are based on strain D7S-1
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Figure 1 Deletion (a) and gene restoration (b) of the 285-island of A actinomycetemcomitans strain D7S-1. (A) The upstream
(1056124e1055349) and downstream (1050261e1049587) regions of the 285-island (1049353e1056070) were amplified and ligated
to the loxP1-Sper-loxP1 cassette in vitro. The 2.7 kb fragment was then used as donor DNA by natural transformation to generate an
intermediate deletion mutant D285::Sper(R). Finally, the plasmid pAT/Cre was introduced and the recombination between two
loxP1 sites removed the Sper marker, resulting in the markerless deletion mutant D285(R); (B) the upstream (1055865e1050253)
and downstream (1050252e1049645) regions of the 285-island were amplified and ligated to the loxP4-Sper-loxP4 cassette in vitro.
The 7.4 kb fragment was then used as donor DNA by natural transformation to generate an intermediate 285-island restored mutant
D 285C::Sper(R). Recombination between two loxP4 sites removed the Sper marker, leaving one copy of loxP4 in the final mar-
kerless 285-island restored mutant D285C(R).
Markerless genetic analysis of A. actinomycetemcomitans 121Cre/loxPmay lead to unexpected deletions or inversions via
recombination between the existing loxP of the genome
and the new loxP introduced by the donor recombinant
DNA, especially if the loxP sites were close to each other.33
Therefore, we developed several loxP sites, each with
a variant spacer based on the previous study that showedTable 4 Doubling times of A. actinomycetemcomitans
wildtype and mutants.
Fimbriated wildtype and derived mutants
Strain Doubling time p valuea
D7S-1 4.86  0.09 e
D7SDltxA 4.79  1.71 1.000
D7SDcdtB 5.53  0.55 0.840
D7SDacrB 5.38  0.21 0.357
D7SDpulG 4.94  0.27 1.000
D7SDp2579 5.82  0.30 0.233
D7SDp2639 5.42  0.31 0.576
D7SD16 5.47  0.62 0.230
D7SD285(R) 2.86  0.24 0.004
D7SDltxADcdtB 5.65  0.15 0.054
D7SDltxADcdtBD16 3.74  0.28 0.135
D7SDltxADcdtBD285 2.17  0.15 0.001
D7SDltxADcdtBD16D285 2.09  0.24 0.011
Gene-restored mutants
Strain Doubling time p valueb
D7SD285C(R) 4.86  0.53 0.678*
D7SDltxADcdtBD285C 6.58  0.57 0.239**
The data are the averages of three independent experiments
and standard deviations are shown. Significant levels are
determined by aone-way ANOVA or bthe Student t test.
*Compared to D7S-1; **compared to D7SDltxADcdtB.incompatibility of certain loxP spacers in recombination.16
We successfully generated deletion mutants of multiple
genes, and did not notice any unexpected problem.
In this study, we restored the deleted genes into the
same locus as in the wildtype bacteria. By this process, only
a loxP scar was introduced into the genome in the gene-
restored mutants. The loxP scar can be placed in a region
which does not affect the phenotypes of the bacteria.
Therefore, the restored mutants have exactly the same
genetic background, and we avoid the problems with other
complementation analysis that may affect gene expression
due to variable copy numbers of the plasmid, different
gene regulation mechanisms of the plasmid and the
genome, or interference from the expression of an antibi-
otic resistance gene of the plasmid. Another advantage is
the relative lack of size constraint for the restored genes. It
is feasible and efficient to restore genes of 10e20 kb in one
experiment.
The growth effect due to the mutation of 285-island was
unexpected. The apparently functional ORFs in the 285-
island are secA, acrA, a marR-family transcriptional regu-
lator and a small hypothetical protein. In E coli, SecA
protein is a major component of the cellular mechanism
which mediates the translocation of proteins across the
plasma membrane,35 and AcrA and AcrB are related to the
multidrug efflux pump, known as two major components of
the tripartite efflux system.36, 37 The MarR (multiple anti-
biotic resistance regulators) family of prokaryotic tran-
scriptional regulators includes proteins critical for control
of virulence factor production, bacterial response to anti-
biotic and oxidative stresses, and catabolism of environ-
mental aromatic compounds.38,39 Therefore, the function
of the 285-island could be for regulation of antibiotic
resistance. However, strain D7S-1 has another efflux pump
homologue. The deletion of the 285-island may or may not
affect its resistance to antibiotics. The E test was
122 Y.-A. Cheng et al.performed to examine the antibiotics resistance profiles of
the 285-island deletion and complementation mutants, but
no corresponding results were shown. More studies are
needed to verify the possible modulation of growth by the
285-island and its mechanism of A actinomycetemcomitans.
In conclusion, this study has demonstrated the feasibility
of employing Cre/loxP recombination system in genetic
manipulation of A actinomycetemcomitans. The protocols
are relatively easy and efficient in the construction of
mutants with deletion of single or multiple genes. The
approach could be used as a tool to identify functional
strain-specific genes or genomic islands for further
hypothesis testing.Acknowledgments
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